9 Meters Biopharma, Inc.

NMTRQ

US6544052086

Investment Holding Companies

Delayed OTC Markets Other stock markets 08:10:19 15/05/2024 pm IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

25/03	North American Morning Briefing : Tech in Focus on -2-	DJ
2023	Bidding Procedure Approved for 9 Meters Biopharma, Inc.	CI

9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President

May 30, 2023 at 06:55 pm IST

9 Meters Biopharma, Inc. announced that the Board of Directors has accepted the resignation of John Temperato as President of the Company effective immediately.

Latest news about 9 Meters Biopharma, Inc.

North American Morning Briefing : Tech in Focus on -2-	25/03	DJ
Bidding Procedure Approved for 9 Meters Biopharma, Inc.	29/11	CI
Amendment to Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	27/11	CI
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	07/11	CI
North American Morning Briefing : Stocks Look to -2-	06/11	DJ
Motion for Asset Sale Filed by 9 Meters Biopharma, Inc.	02/11	CI
North American Morning Briefing : Stock Futures -2-	22/23/22	DJ
North American Morning Briefing : Mood Seen Buoyed -2-	15/23/15	DJ
North American Morning Briefing : Apple's China Conflict, Rate Hike Fears Continue to Weigh	08/23/08	DJ
North American Morning Briefing : Jobs Report Eyed for Hiring Slowdown	01/23/01	DJ
North American Morning Briefing : Investors Await Powell's Jackson Hole Speech	25/23/25	DJ
North American Morning Briefing : China Trouble Hits Sentiment	18/23/18	DJ
North American Morning Briefing : Stock Futures -2-	11/23/11	DJ
Illumina cuts annual profit forecast as biotech funding woes linger	10/23/10	RE
Illumina cuts annual profit forecast	10/23/10	RE
9 Meters Biopharma, Inc.(OTCPK:NMTR.Q) dropped from NASDAQ Composite Index	25/23/25	CI
9 Meters Biopharma, Inc.(NasdaqCM:NMTR) dropped from S&P TMI Index	21/23/21	CI
Drug developer 9 Meters Biopharma files for bankruptcy protection	18/23/18	RE
9 Meters Biopharma, Inc. Filed for Bankruptcy	17/23/17	CI
9 Meters Biopharma Names Bethany Sensenig Interim Chief Executive; Shares Fall	30/23/30	MT
9 Meters Biopharma, Inc. Provides Clinical Update on Vurolenatide in Patients with Short Bowel Syndrome	30/23/30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President	30/23/30	CI
9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as Chief Executive Officer	30/23/30	CI
9 Meters Biopharma, Inc. Appoints Bethany Sensenig as Interim CEO	30/23/30	CI
Citigroup Adjusts 9 Meters Biopharma Price Target to $0.75 From $1.70, Maintains Neutral Rating	18/23/18	MT

Chart 9 Meters Biopharma, Inc.

Duration

Period

More charts

9 Meters Biopharma, Inc. has ceased operations. The Company has filed a voluntary petition for relief under provisions of Chapter 7 of Title 11 of the United States Code (the Bankruptcy Code) in the United States Bankruptcy Court for the Eastern District of North Carolina.

Sector

Investment Holding Companies

More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Shell Companies

	1st Jan change	Capi.
9 METERS BIOPHARMA, INC.	0.00%	14
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+195.31%	7.3B
CHURCHILL CAPITAL CORP VII	+2.10%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+23.55%	799M
ARES ACQUISITION CORPORATION II	+1.72%	661M
E7 GROUP	+5.92%	653M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies

9 Meters Biopharma, Inc.

Equities

NMTRQ

US6544052086

Investment Holding Companies

9 Meters Biopharma, Inc. Announces the Resignation of John Temperato as President

Latest news about 9 Meters Biopharma, Inc.

Chart 9 Meters Biopharma, Inc.

Company Profile

Income Statement Evolution

Quarterly earnings - Rate of surprise

Sector Shell Companies